The trademark application SYMBRAHALE was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on May 23, 2022, and it was registered by office on August 30, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1738692 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).